No Detail Found!

Fabry disease in South and Central Asia: Is it truly a rare disease or underappreciated?

Author(s)
Sahrai Saeed Department of Heart Disease, Haukeland University Hospital, Bergenm Norway
Massimo Imazio Department University Hospital, 'Santa Marta Della Misericondia', ASUFC, Udine, Italy.
Abstract
Fabry disease (FD) is a relatively rare X-linked hereditary disease caused by mutations in the GLA gene that results in deficient a-galactosidase A (a-Gal A) enzyme activity. The disturbed catabolism of the neutral sphingolipids globotriaosylceramide (Gb3) leads to its progressive lysosomal accumulation throughout the body. Multiple organs can be affected. The atypical late-onset cardiac variant is associated with a high burden of cardiac morbidity and mortality. The true burden of FD in Central and some South Asian countries is unknown. Lack of research studies and awareness, and misdiagnosis/underdiagnosis may be the reasons. Some possible explanations as well suggestions for a structured Fabry care and research possibilities in these WHO regions are offered.
Publication Details
Page(s) 1-3
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 38, Issue: 8, Year: 2022

Request the full text from PASTIC

Keywords
Cardiomyopathy, Fabry Disease, South and Central Asia, pIncidence, Enzyme replacement therapy
0

Citations

0

Downloads

152

Views